These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16772881

  • 1. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma.
    Rhodes MM, Delbeke D, Whitlock JA, Martin W, Kuttesch JF, Frangoul HA, Shankar S.
    J Pediatr Hematol Oncol; 2006 May; 28(5):300-6. PubMed ID: 16772881
    [Abstract] [Full Text] [Related]

  • 2. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
    Hart DP, Avivi I, Thomson KJ, Peggs KS, Morris EC, Goldstone AH, Linch DC, Ell PJ, Bomanji JB, Mackinnon S.
    Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FDG PET-CT in the management of primary breast lymphoma.
    Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.
    Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815
    [Abstract] [Full Text] [Related]

  • 5. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
    Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D'Amore F, Boesen AM, Roemer L, Specht L.
    Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 9. FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
    Bjurberg M, Gustavsson A, Ohlsson T, Brun E.
    Acta Oncol; 2006 Dec; 45(6):743-9. PubMed ID: 16938818
    [Abstract] [Full Text] [Related]

  • 10. SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET?
    Furth C, Meseck RM, Steffen IG, Schoenberger S, Denecke T, Henze G, Hautzel H, Hofheinz F, Großer O, Hundsdoerfer P, Amthauer H, Ruf J.
    Pediatr Blood Cancer; 2012 Sep; 59(3):475-80. PubMed ID: 22190514
    [Abstract] [Full Text] [Related]

  • 11. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S.
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
    [Abstract] [Full Text] [Related]

  • 13. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.
    Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A.
    Pediatr Radiol; 2006 Jun; 36(6):524-31. PubMed ID: 16622665
    [Abstract] [Full Text] [Related]

  • 14. The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.
    Bhojwani D, McCarville MB, Choi JK, Sawyer J, Metzger ML, Inaba H, Davidoff AM, Gold R, Shulkin BL, Sandlund JT.
    Br J Haematol; 2015 Mar; 168(6):845-53. PubMed ID: 25382494
    [Abstract] [Full Text] [Related]

  • 15. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
    Crocchiolo R, Fallanca F, Giovacchini G, Ferreri AJ, Assanelli A, Verona C, Pescarollo A, Bregni M, Ponzoni M, Gianolli L, Fazio F, Ciceri F.
    Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
    Mody RJ, Bui C, Hutchinson RJ, Frey KA, Shulkin BL.
    Leuk Lymphoma; 2007 Apr; 48(4):699-707. PubMed ID: 17454627
    [Abstract] [Full Text] [Related]

  • 19. [Quantitative and qualitative evaluation of the interim PET/CT in lymphoma treatment in the prediction of complete metabolic response].
    Pilkington Woll JP, García Vicente AM, Talavera Rubio MP, Palomar Muñoz AM, Jiménez Londoño G, León Martín A, Calle Primo C, Soriano Castejón AM.
    Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):70-6. PubMed ID: 22759992
    [Abstract] [Full Text] [Related]

  • 20. Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma.
    Meany HJ, Gidvani VK, Minniti CP.
    Pediatr Blood Cancer; 2007 Apr; 48(4):399-402. PubMed ID: 16514616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.